Sun Yat-sen University: all 1,681 studies

Page 10 of 17. Open to participants first (610), then studies with results posted, then the rest; newest registration first within each.

• Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTLStatus unknownNCT04676789Phase 2
• HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority TrialStatus unknownNCT04667351Phase 3
• Maternal and Infant Health and Breast Milk Study in South ChinaCompletedNCT04655820
• Total-body PET/CT Imaging Using the uEXPLORER in Non-small Cell Lung Cancer Patients Treated by Induction Chemotherapy Plus Nivolumab and Definitive Concurrent ChemoradiotherapyCompletedNCT04654234
• Ablation Combined With PD-1 in HCC: Phase II StudyStatus unknownNCT04652440Phase 1/2
• Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical CancerTerminatedNCT04651127Phase 1/2
• TIPS Combined With Microwave Ablation in HCC Patients With Refractory AscitesStatus unknownNCT04640116Not applicable
• Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal CarcinomaCompletedNCT04636632Phase 1
• Effect of Prebiotics on Blood Glucose ManagementStatus unknownNCT04636489Not applicable
• Accuracy of Digital Implant ImpressionStatus unknownNCT04627649
• HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular CarcinamaStatus unknownNCT04627363Phase 2
• Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular CarcinomaCompletedNCT04627012
• A Novel Prognostic Model of NPI for Risk-Predicting and Clinical Decision-making in Diffuse Large B-Cell Lymphoma in the Rituximab EraStatus unknownNCT04624971
• Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance with Zanubrutinib for Newly-Diagnosed MCLActive, not recruitingNCT04624958Phase 2
• HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTTCompletedNCT04618367Not applicable
• A Multi-center, Retrospective Analysis of Clinical Character, Outcome and Prognosis of Lymphoepithelioma-like CarcinomaStatus unknownNCT04614818
• Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue SarcomaStatus unknownNCT04606108Phase 2
• Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast CancerStatus unknownNCT04605575Phase 2
• Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade GliomaStatus unknownNCT04588987Phase 2
• Adalimumab Plus Methotrexate for the Treatment of Pediatric UveitisStatus unknownNCT04588818Phase 2
• Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment FailureActive, not recruitingNCT04586088Phase 2
• Nab-PTX, Ifosfamide and Cisplatin in the Treatment of Pediatric Extracranial Germ Cell Tumor.Status unknownNCT04581265Phase 2
• A Study of Radiotherapy Planning System Software ---- Zeus CloudStatus unknownNCT04579718
• Molecular Profiling and Molecular Labeling of Inflammatory Myofibroblastic TumorStatus unknownNCT04572594
• Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial CarcinomaCompletedNCT04562311Phase 2
• Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC PatientsCompletedNCT04548440Phase 2
• Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAOStatus unknownNCT04548284Phase 3
• Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT04548271Phase 2
• Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After ChemotherapyStatus unknownNCT04547829Phase 2
• Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT04547088Phase 2
• Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal CancerStatus unknownNCT04539600Phase 2
• A Cross-sectional Study for Renal Function of Patients With Chronic Hepatitis B in ChinaStatus unknownNCT04538651
• Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 StudyStatus unknownNCT04536558Phase 3
• Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLCStatus unknownNCT04524299Phase 2
• Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric PatientsCompletedNCT04508400Phase 2
• Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLCCompletedNCT04507217Phase 2
• Treating Locally Advanced Head and Neck Malignant Tumor With Anlotinib and ChemoradiotherapyStatus unknownNCT04507035Phase 4
• The mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and SurvivalCompletedNCT04482608
• A Study of DC-CIK Immunotherapy in the Treatment of Solid TumorsStatus unknownNCT04476641Phase 2
• TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile CancerCompletedNCT04475016Phase 2
• Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal CarcinomaStatus unknownNCT04472403
• A Retrospective Cohort Study: Influence of MTHFR C677T and A1298C Polymorphisms on the Survival of Pediatric Patients With Non-Hodgkin's LymphomaCompletedNCT04469543
• The Molecular Mechanism of RAS Wild-type mCRC Resistance to Anti-EGFR-antibodyCompletedNCT04466267
• Conjunctival Autograft or Limbal Conjunctival Autograft for Recurrent Pterygium Using Mitomycin CStatus unknownNCT04463901Not applicable
• Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal CarcinomaActive, not recruitingNCT04456322Phase 3
• Quantitative Evaluation of Parafoveal Microvasculature Changes in Eyes With Exudative Circumscribed Choroidal Haemangioma: An Optical Coherence Tomography Angiography StudyCompletedNCT04449900
• Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical CarcinomaStatus unknownNCT04443296Phase 1
• Longitudinal Changes in Refractive Error After Primary IOL Implantation Among Children With Congenital CataractCompletedNCT04441268
• Photodynamic Therapy With Visudyne for Human Retinoblastoma: A Preliminary StudyCompletedNCT04429139Not applicable
• Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell LymphomaStatus unknownNCT04423549
• Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell LymphomaStatus unknownNCT04423536
• Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent ChemoradiotherapyTerminatedNCT04418648Phase 2
• Validation of the Utility of Strabismus Intelligent Diagnostic SystemStatus unknownNCT04416776
• Dry Eye Screening and Referral SystemCompletedNCT04413370
• Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma.Status unknownNCT04405622Phase 2
• Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant TumorsStatus unknownNCT04400851Phase 1
• Systemic Chemotherapy Plus PD-1 for Metastasis ICCWithdrawnNCT04398927Phase 2
• Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal CarcinomaStatus unknownNCT04398056Phase 2
• Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung CancerStatus unknownNCT04397926Phase 1
• GM1 Prophylaxis for WBRT Related Cognitive DysfunctionTerminatedNCT04395339Phase 3
• Post-treatment Ultrasensitive Positron Emission Tomography in Nasopharyngeal Carcinoma PatientsStatus unknownNCT04394091
• uEXPLORER Total-body PET/CT in Nasopharyngeal CarcinomaCompletedNCT04394065
• A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative ResectionStatus unknownNCT04392700Phase 3
• Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent ChemoradiotherapyActive, not recruitingNCT04384627Phase 3
• Sutures in Orbital Implants in Retinoblastoma PatientsCompletedNCT04383860Not applicable
• Percutaneous Endoscopic Gastrostomy Before Definitive Concurrent Chemoradiation Therapy for Esophageal Squamous Cell CarcinomaCompletedNCT04380480Phase 2
• Nab-Paclitaxel and Gemcitabine Plus Camrelizumab and Radiotherapy for Locally Advanced Pancreatic AdenocarcinomaStatus unknownNCT04365049
• Correlation Between Refraction and Biometric ParametersStatus unknownNCT04346251
• Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLCCompletedNCT04345146Phase 2
• Glaucoma After Congenital Cataract SurgeryStatus unknownNCT04342052
• Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical CancerCompletedNCT04341883Phase 2
• Academic Performance and Refractive ErrorStatus unknownNCT04338880
• Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in ChinaStatus unknownNCT04334330Phase 2
• Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder CancerStatus unknownNCT04333927Phase 2
• Comparison of Traditional Cataract Surgery and Traditional Surgery Combined Triamcinolone StainingStatus unknownNCT04323982Not applicable
• A Multicenter Prospective Study of "High Risk" Molecular Typing in Patients With Adult T Lymphoblastic LymphomaStatus unknownNCT04320992
• TAEST16001 in the Treatment of Soft Tissue SarcomaStatus unknownNCT04318964Phase 1
• Artificial Intelligence System for Assessing Image Quality of Slit-Lamp Images and Its Effects on DiagnosisStatus unknownNCT04314180
• Reducing Eye Strain and Anxiety Using a Digital Intervention During Online Learning Class Recess Among Children at Home: A Randomized Controlled TrialCompletedNCT04309097Not applicable
• Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal CancerActive, not recruitingNCT04304209Phase 2
• Myopic Optic Neuropathy in Chinese High Myopia PopulationActive, not recruitingNCT04302220
• PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal CancerActive, not recruitingNCT04301557Phase 2
• Effect of Lowering IOP in Glaucoma Suspects With HMStatus unknownNCT04296916Not applicable
• Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of OsteosarcomaStatus unknownNCT04294511Phase 2
• Artificial Intelligence System for Assessing Image Quality of Fundus Images and Its Effects on DiagnosisStatus unknownNCT04289064
• A Retrospective Cohort Study: The Influence of MTHFR C677T and A1298C on the High-dose Methotrexate-Related Toxicities in Pediatric Patients With Non-Hodgkin LymphomaCompletedNCT04283955
• Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung CancerStatus unknownNCT04275687Phase 2
• Validation of a Predictive Algorithm to Determine the Effectiveness of Orthokeratology for Myopia ControlStatus unknownNCT04275635
• Effects of Caloric Restriction and Exercise on Body Weight, Immune Function, and Intestinal FloraCompletedNCT04275440Not applicable
• Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal CancerActive, not recruitingNCT04262635Phase 3
• Effectiveness of an Interactive Consulting System to Enhance Patients' Decision-making: A Randomized Controlled TrialCompletedNCT04262596Not applicable
• Pyrotinib in Breast Cancer Patients With Poor Response to the Neoadjuvant Treatment of Trastuzumab and PertuzumabStatus unknownNCT04255056Phase 2
• Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AMLStatus unknownNCT04254640Phase 2
• Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric CancerActive, not recruitingNCT04250948Phase 2
• Diagnostic Performance of Deep Learning for Angle ClosureStatus unknownNCT04242108
• Evaluation ctDNA in Patients of Non-Small-Cell Lung Cancer Following ResectionCompletedNCT04238130
• Video Screening for Visual Impairment of InfantsCompletedNCT04237350
• Eye Movement and Cognitive DysfunctionCompletedNCT04236375
• Prospective Screening Programme for Malignant TumorsStatus unknownNCT04230200
• The Gene Profiles of Primary and Heterogeneous Metastases of Colorectal CancerStatus unknownNCT04230018

← Sun Yat-sen University overview and focus areas